Ignite Creation Date:
2024-05-06 @ 9:11 AM
Last Modification Date:
2024-10-26 @ 12:11 PM
Study NCT ID:
NCT02924376
Status:
COMPLETED
Last Update Posted:
2023-02-23
First Post:
2016-10-04
Brief Title:
Efficacy and Safety of Pemigatinib in Subjects With AdvancedMetastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - FIGHT-202
Sponsor:
Organization:
Incyte Corporation